Literature DB >> 21697134

Role of adenosine in the control of choroidal blood flow during changes in ocular perfusion pressure.

Doreen Schmidl1, Guenther Weigert, Guido T Dorner, Hemma Resch, Julia Kolodjaschna, Michael Wolzt, Gerhard Garhofer, Leopold Schmetterer.   

Abstract

PURPOSE: The purpose of the present study was to investigate whether the nucleoside adenosine is involved in the regulatory processes of choroidal blood flow (ChBF) during an experimental decrease in ocular perfusion pressure (OPP).
METHODS: In this randomized, double-masked, placebo-controlled, two-way crossover study, 14 subjects received either intravenous adenosine or placebo on two different study days. The suction cup method was used for a stepwise increase in intraocular pressure (IOP). Subfoveal ChBF was measured by laser Doppler flowmetry. Mean arterial pressure (MAP) and IOP were measured noninvasively. Ocular perfusion pressure was calculated as OPP = 2/3MAP - IOP.
RESULTS: Adenosine increased ChBF significantly versus placebo before application of the suction cup (P < 0.05). When the suction cup was applied, a significant decrease in OPP was observed. This effect was comparable on all study days. The decrease in OPP was paralleled by a significant decrease in ChBF (maximum between -43% and -52%) which was less pronounced than the decrease in OPP (maximum between -62% and -64%). Neither placebo nor adenosine influenced the ChBF increase during suction cup-induced changes in OPP.
CONCLUSIONS: The data of the present study confirm that the human choroid shows some regulatory capacity during a decrease in OPP. Adenosine influences basal vascular tone in the choroid but is not involved in the regulatory mechanisms during an increase in IOP. (ClinicalTrials.gov number, NCT00712764.).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697134     DOI: 10.1167/iovs.11-7491

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Changes in choroidal thickness, axial length, and ocular perfusion pressure accompanying successful glaucoma filtration surgery.

Authors:  N Kara; O Baz; C Altan; B Satana; T Kurt; A Demirok
Journal:  Eye (Lond)       Date:  2013-06-07       Impact factor: 3.775

2.  Regulation of optic nerve head blood flow during combined changes in intraocular pressure and arterial blood pressure.

Authors:  Agnes Boltz; Doreen Schmidl; René M Werkmeister; Michael Lasta; Semira Kaya; Stefan Palkovits; Reinhard Told; Katarzyna J Napora; Alina Popa-Cherecheanu; Gerhard Garhöfer; Leopold Schmetterer
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

3.  Measurement of choroidal thickness and macular thickness during and after pregnancy.

Authors:  Döndü Melek Ulusoy; Necati Duru; Mustafa Ataş; Hasan Altınkaynak; Zeynep Duru; Gökhan Açmaz
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

4.  Choroidal thickness changes after dynamic exercise as measured by spectral-domain optical coherence tomography.

Authors:  Nihat Sayin; Necip Kara; Gokhan Pekel; Hasan Altinkaynak
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

5.  Trabodenoson, an Adenosine Mimetic With A1 Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice.

Authors:  Guorong Li; Karen Y Torrejon; Andrea M Unser; Feryan Ahmed; Iris D Navarro; Rudolf A Baumgartner; David S Albers; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

6.  Changes in Retinal Blood Flow in Response to an Experimental Increase in IOP in Healthy Participants as Assessed With Doppler Optical Coherence Tomography.

Authors:  Stefan Puchner; Doreen Schmidl; Laurin Ginner; Marco Augustin; Rainer Leitgeb; Stephan Szegedi; Kristina Stjepanek; Nikolaus Hommer; Martin Kallab; René Marcel Werkmeister; Leopold Schmetterer; Gerhard Garhofer
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.